Oben Ojong
Dermatology Physician in The Woodlands, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,645 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Oben Ojong reported a CMS MIPS final score of 79.6/100 - below the 83.1 national average - and filed 1,818 Medicare Part D claims in 2023.
- 79.6/100
- MIPS score · -3 vs avg
- 2K
- Part D claims, 2023
- 88%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Oben Ojong's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
80 30th percentile higher than 30% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Oben Ojong sits
This provider among dermatology physician peers
Across the 6,594 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Oben Ojong writes more Part D claims than 92% of them and scores higher on MIPS quality than 39% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is Oben Ojong. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Oben Ojong practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Oben Ojong?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Dermatology Physician compares to other specialties among Texas providers
Dermatology Physician ranks #65 among Texas's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Dermatology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Oben Ojong's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 79.6/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) - 79.6/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Dermatology Physician US NPIs
79.6/100 MIPS final score - 3.5 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 81.8. Cost dim: 56.1.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Oben Ojong appears in the CMS NPPES registry as a Dermatology Physician provider at 9323 PINECROFT DR STE 202, The Woodlands, TX, 77380, with a listed phone of (832) 663-0427. NPI 1619416286 was issued on 02/15/2017.
Medicare Part D records for calendar year 2023 show 1,818 prescription claims written by this provider, covering 547 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 12% brand-name and 88% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 79.6/100 for the 2023 performance year (Quality 81.8, Cost 56.1), compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,645 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1619416286 |
|---|---|
| Specialty | Dermatology Physician |
| Gender | Female |
| NPI Issued | 02/15/2017 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Oben Ojong's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1619416286 is the unique 10-digit identifier CMS uses to link Ojong across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Oben Ojong. Source: openpaymentsdata.cms.gov.
Total received
$219
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Oben Ojong. To verify Oben Ojong's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
12% brand-name claims vs 88% generic, on 1,818 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,105
- Total Day Supply
- 51,569
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $54K
- Antibiotic Claims
- 341
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.61
- Gender Split
- 50% female / 50% male
- Age Distribution
- <65: 60, 65-74: 234, 75-84: 194, 85+: 59
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Oben Ojong prescribes most
Top Medicare Part D drugs by claim count, 2023
- Doxycycline Hyclate
Doxycycline Hyclate
271 claims
- Ketoconazole
Ketoconazole
259 claims
- Betamethasone Dipr…
Betamethasone Dipropionate
135 claims
- Triamcinolone Acet… 108
Triamcinolone Acetonide
108 claims
- Clobetasol Propion… 98
Clobetasol Propionate
98 claims
- Mupirocin 87
Mupirocin
87 claims
- Hydrocortisone 64
Hydrocortisone
64 claims
- Dupixent Pen 57
Dupixent Pen
57 claims
| Drug | Claims |
|---|---|
| Doxycycline Hyclate | 271 |
| Ketoconazole | 259 |
| Betamethasone Dipropionate | 135 |
| Triamcinolone Acetonide | 108 |
| Clobetasol Propionate | 98 |
| Mupirocin | 87 |
| Hydrocortisone | 64 |
| Dupixent Pen Dupilumab | 57 |
| Clindamycin Phosphate | 55 |
| Cephalexin | 45 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Oben Ojong fits within the Dermatology Physician landscape nationally.
Oben Ojong's 1,818 claims are above the specialty average of 729.
Nearby Dermatology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Ojong.
Compare Dermatology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Dermatology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Oben Ojong's specialty? ▼
How much does Oben Ojong prescribe under Medicare Part D? ▼
What is Oben Ojong's Medicare quality score? ▼
Where is Oben Ojong located? ▼
What is Oben Ojong's NPI number? ▼
Does Oben Ojong prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does Oben Ojong prescribe most often? ▼
Does Oben Ojong accept Medicare? ▼
How can I verify Oben Ojong's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.